Site Search

Share

X

Search Results

Texas Becomes Latest State to Improve Access to Biomarker Testing, Beating New York in Push to Prioritize Precision Medicine

... TX – MAY 30, 2023 – Yesterday, Texas Governor Greg Abbott signed Senate Bill 989 into law, making Texas the 11 th state to expand access to biomarker testing. New York is considering comparable legislation through Assembly Bill 1673 / Senate Bill 1196. The American Cancer Society Cancer Action ... responded to the legislative victory in Texas with the following statement:   “Texas has joined a growing list of states expanding access to biomarker testing. The clock is ticking for New York to do the same. We cannot wait any longer to act on Assembly Bill 1673 / Senate Bill 1196. ...

Victory for Public Health: ACS CAN Applauds Decision to Reject Flawed Biomarker Legislation

... CAN) in West Virginia: "The American Cancer Society Cancer Action Network (ACS CAN) applauds the Senate for not supporting House Bill 4753, the biomarker testing legislation, which was supposed to allow West Virginians to get the testing they need and not fall farther behind other states. West Virginia patients deserve access to proven and necessary biomarker tests that can allow them to benefit from the right treatments at the right time – often leading to improved health outcomes, better ...

**MEDIA ADVISORY—SPOKESPEOPLE AVAILABLE** Cancer Action Day Brings Advocates to Capitol in Support of “Jill’s Law” Ensuring Access to Biomarker Testing

... Day . They will urge state lawmakers to make cancer policy a priority by passing House Bill 565 “Jill’s Law,” guaranteeing coverage of biomarker testing for all Mississippians with state-regulated health insurance plans. The group will hold a news conference at 10:30 a.m. and meet with lawmakers throughout the day. Jill’s Law is named for Jill Eure, the late wife of Rep. Casey Eure who benefited from biomarker testing. In the case of a cancer diagnosis, biomarker testing helps doctors determine the right treatment, saving some patients from ...

**MEDIA ALERT – NEWS CONFERENCE** Patient Advocates Join Together at Capitol to Call for Passage of Crucial Biomarker Testing Coverage Bill

... together on Tuesday, February 3, to host a news conference calling on lawmakers to pass legislation that would ensure appropriate coverage of biomarker testing. The news conference is part of ACS CAN's annual Cancer Action Day . Biomarker testing has become an increasingly important tool in treating many cancers and diagnosing Alzheimer's disease. It also can help in ...

Cancer Advocates Commend Colorado Lawmakers for Positive First Step in Opening Door to Precision Medicine

... Cancer Society Cancer Action Network (ACS CAN) applauds the Colorado General Assembly for taking a great first step to increasing access to biomarker testing by passing SB24-124. The bill was met with strong bi-partisan support in both the House and Senate. With the legislative process now ... enacted, the policy would help connect more patients diagnosed with cancer or other diseases with the right treatment at the right time through biomarker testing .  The bill would ensure more patients with private insurance will have health insurance coverage for the biomarker testing they ...

Georgia General Assembly Passes Bill That Could Improve Cancer Survivorship by Expanding Access to Biomarker Testing, Necessary First Step in Personalizing Treatment

... 2023 – After a final vote by the Senate, the Georgia General Assembly today passed a bill (HB 85) that is expected to provide more access to biomarker testing, which is testing that can help physicians to identify the most effective treatment for a patient’s disease.   Revolutionizing cancer treatment over the last few decades, biomarker testing can provide access to targeted treatment; tailoring care to a person’s individual disease. Targeted therapies often result in ...

Legislation Aimed at Improving Health Outcomes for Pennsylvanians Heads to the Governor’s Desk

Earlier today, the Pennsylvania State Senate unanimously passed House Bill 1754, the bipartisan proposal to increase access to biomarker testing. The bill will now go to Governor Shapiro’s desk, providing him the opportunity to ensure coverage of this essential testing for more Pennsylvanians. The American Cancer Society Cancer Action Network (ACS CAN) and the PA Biomarker Testing Coalition are advocating for this significant policy change to ensure more cancer patients and people with other illnesses and ...

Senate Takes Step to Ensure Cancer Patients Get the Right Treatment Faster

SPRINGFIELD, IL – This afternoon, the Illinois Senate passed Senate Bill 3509, which would improve access to biomarker testing, a game-changer in the fight against cancer and other conditions, and an essential step toward accessing precision treatments.  The ... ago, Illinois made history when it became the first state in the country to pass legislation expanding insurance coverage for evidence-based biomarker testing. Since then, twenty-two states have followed Illinois’ lead, enacting similar laws to improve access to this valuable testing. ...

Illinois Advances Legislation to Get Cancer Patients the Right Treatment Faster

SPRINGFIELD, IL – The state legislature has passed Senate Bill 3509, which would improve access to biomarker testing, a game-changer in the fight against cancer and other conditions, and an essential step toward accessing precision treatments.  The ... ago, Illinois made history when it became the first state in the country to pass legislation expanding insurance coverage for evidence-based biomarker testing. Since then, twenty-three states have followed Illinois’ lead, enacting similar laws to improve access to this valuable ...

NYS Senate Rejects Medicaid Rollback of Biomarker Testing Coverage Criteria, Patient Advocates Urge Governor & Assembly to Follow Suit in Final Budget

... of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer ... Clinical practice guidelines are the most frequently consulted resource in deciding whether to recommend or order biomarker testing, cited by 91% of oncology providers in a recent survey.    In response, Michael Davoli, who serves as the senior government ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy